[Therapy of intestinal carcinoidosis].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001920:Bradykinin / Q000037:antagonists & inhibitors; D002276:Carcinoid Tumor / Q000188:drug therapy*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007414:Intestinal Neoplasms / Q000188:drug therapy* / Q000601:surgery; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy*; D008784:Methysergide / Q000627:therapeutic use; D010649:Phenylalanine / Q000627:therapeutic use; D012702:Serotonin Antagonists
D000970:Antineoplastic Agents; D006634:Histamine H1 Antagonists; D012702:Serotonin Antagonists; D010649:Phenylalanine; D001920:Bradykinin; D008784:Methysergide
Terapia della carcinoidosi intestinale.